| [1] |
Mangione C M, Barry M J, Nicholson W K, et al. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement[J]. JAMA, 2023, 329(17):1487-1494. doi:10.1001/jama.2023.4899.
|
| [2] |
Louie J K, Keh C E. Latent Tuberculosis Infection Treatment: Still a Long Road Ahead[J]. Clin Infect Dis, 2023, 77(2):295-297. doi:10.1093/cid/ciad251.
pmid: 37125504
|
| [3] |
高磊, 张慧, 胡茂桂, 等. 基于多中心调查数据和空间统计模型的全国结核分枝杆菌潜伏感染率估算[J]. 中国防痨杂志, 2022, 44(1):54-59. doi:10.19982/j.issn.1000-6621.2022.01.005.
|
| [4] |
周林, 初乃惠, 陆伟. 高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识[J]. 中国防痨杂志, 2021, 43(9):874-878. doi:10.3969/j.issn.1000-6621.2021.09.004.
|
| [5] |
中华人民共和国国家卫生健康委员会. 2024年我国卫生健康事业发展统计公报[EB/OL]. ((2025-12-02)[2026-07-16]. https://www.nhc.gov.cn/guihuaxxs/c100133/202512/f1c3a3c617484a27a1a26a468afbaeee/files/2024年我国卫生健康事业发展统计公报-20251201161542231.pdf
|
| [6] |
张旭辉, 张景暄, 付庭吕, 等. 尘肺共病肺结核的系统性综述[J]. 工业卫生与职业病, 2025, 51(4):370-374. doi:10.13692/j.cnki.gywsyzyb.2025.04.017.
|
| [7] |
中华预防医学会劳动卫生与职业病分会职业性肺部疾病学组. 尘肺病治疗中国专家共识(2024年版)[J]. 环境与职业医学, 2024, 41(1):1-21. doi:10.11836/JEOM23379.
|
| [8] |
Ehrlich R, Murray J, Said-Hartley Q, et al. Silicotuberculosis: a critical narrative review[J]. Eur Respir Rev, 2024, 33(174):240168. doi:10.1183/16000617.0168-2024.
|
| [9] |
Albadrani M. Exploring the Impact of Silicosis Incidence on Tuberculosis Mortality and Morbidity: A Multi-Country Study[J]. Med Sci (Basel), 2023, 11(4):63. doi:10.3390/medsci11040063.
|
| [10] |
Guidelines for the use of the ILO international Classification of Radiographs of Pneumoconioses (Revised edition 2022)[J]. Sangyo Eiseigaku Zasshi, 2025, 67(supplement):1-23. doi:10.1539/sangyoeisei.2025-ilo-guideline-jpn.
|
| [11] |
中华人民共和国国家卫生和计划生育委员会. GBZ 70-2015 职业性尘肺病的诊断[S]. 2015-12-15.
|
| [12] |
World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention: tuberculosis preventive treatment[R]. Geneva: World Health Organization, 2020.
|
| [13] |
中华人民共和国国家卫生和计划生育委员会. WS 288-2017肺结核诊断[J]. 结核与肺部疾病杂志, 2024, 5(4): 376-378. doi:10.19983/j.issn.2096-8493.2024022.
|
| [14] |
国家疾病预防控制局, 中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 等. 关于印发《全国结核病防治规划(2024-2030年)》的通知[EB/OL]. 国疾控传防发〔2024〕19号.2024-11-28. https://www.gov.cn/zhengce/zhengceku/202412/content_6991217.htm.
|
| [15] |
中华人民共和国国家卫生健康委员会. 2024中国卫生健康统计年鉴[M]. 北京: 中国协和医科大学出版社, 2025.
|
| [16] |
孙澜, 郭奕梅, 张海龙. 安顺市石雕从业者尘肺合并肺结核潜伏感染的现状研究[J]. 智慧健康, 2024, 10(24):4-6. doi:10.19335/j.cnki.2096-1219.2024.24.002.
|
| [17] |
Jin Y, Wang H, Zhang J, et al. Prevalence of latent tuberculosis infection among coal workers’ pneumoconiosis patients in China: a cross-sectional study[J]. BMC Public Health, 2018, 18(1):473. doi:10.1186/s12889-018-5373-1.
|
| [18] |
Ringshausen F C, Nienhaus A, Schablon A, et al. Frequent Detection of Latent Tuberculosis Infection among Aged Underground Hard Coal Miners in the Absence of Recent Tuberculosis Exposure[J]. PLoS One, 2013, 8(12):e82005. doi:10.1371/journal.pone.0082005.
|
| [19] |
Hu X, Chen C, Gao Q, et al. Latent tuberculosis infection and infection-associated risk factors for miner workers with silicosis in eastern China[J]. BMC Pulm Med, 2024, 24(1):177. doi:10.1186/s12890-024-02985-z.
pmid: 38622607
|
| [20] |
Yang Q, Lin M, He Z, et al. Mycobacterium tuberculosis Infection among 1,659 Silicosis Patients in Zhejiang Province, China[J]. Microbiol Spectr, 2022, 10(6):e0145122. doi:10.1128/spectrum.01451-22.
|
| [21] |
梁倩, 龙莹, 李蕊丹, 等. 四川省某院矽肺住院患者流行病学特征及结核潜伏感染率分析[J]. 现代预防医学, 2021, 48(15):2730-2733, 2754. doi:10.20043/j.cnki.mpm.2021.15.010.
|
| [22] |
陈明凤. 退休煤工尘肺潜伏性结核感染转归的随访研究[D]. 北京: 中国疾病预防控制中心, 2021.
|
| [23] |
肖泽蕾, 陈峭. 煤工尘肺患者的结核潜伏感染风险及危险因素分析[J]. 四川生理科学杂志, 2024, 46(9):1930-1932,1977.
|
| [24] |
郭倩文, 朱晓敏, 朱芳, 等. 接尘作业工人尘肺患者结核潜伏性感染的患病情况及影响因素分析[J]. 实用预防医学, 2020, 27(9):1122-1124. doi:10.3969/j.issn.1006-3110.2020.09.027.
|
| [25] |
全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告[J]. 中国防痨杂志, 2012, 34(8):485-508.
|
| [26] |
Wang H, Ye Q, Chen Y, et al. Epidemiology of coal miners’ pneumoconiosis and its social determinants: An ecological study from 1949 to 2021 in China[J]. Chin Med J Pulm Crit Care Med, 2023, 1(1):46-55. doi:10.1016/j.pccm.2023.03.002.
|
| [27] |
Gong X, Cui K, Liu Z, et al. The disease burden of pneumoconiosis in China from 1990 to 2021 and projection to 2050 based on GBD 2021: a cross-sectional study[J]. Front Public Health, 2025, 13:1583895. doi:10.3389/fpubh.2025.1583895.
|
| [28] |
郑亦沐, 赵赞梅, 李晓, 等. 2014-2023年北京市某职业病诊断机构职业病诊断受理及确诊情况分析[J]. 中国煤炭工业医学杂志, 2025, 28(1):96-100. doi:10.11723/mtgyyx1007-9564202501012.
|
| [29] |
Ehrlich R, Akugizibwe P, Siegfried N, et al. The association between silica exposure, silicosis and tuberculosis: a systematic review and meta-analysis[J]. BMC Public Health, 2021, 21(1):953. doi:10.1186/s12889-021-10711-1.
pmid: 34016067
|
| [30] |
Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study[J]. Lancet Infect Dis, 2015, 15(3):310-319. doi:10.1016/s1473-3099(14)71085-0.
pmid: 25681063
|
| [31] |
Ranjan A, Panneerselvam A, Meena S, et al. Silicotuberculosis: Newer trends[J]. Indian J Tuberc, 2025, 72(4):521-526. doi:10.1016/j.ijtb.2025.01.010.
pmid: 40975585
|
| [32] |
Chen H, Tao X, Cao H, et al. Nicotine exposure exacerbates silica-induced pulmonary fibrosis via STAT3-BDNF-TrkB-mediated epithelial-mesenchymal transition in alveolar type Ⅱ cells[J]. Food Chem Toxicol, 2023, 175:113694. doi:10.1016/j.fct.2023.113694.
|
| [33] |
Mutua F, Su R C, Ball T B, et al. The Role of Type I Interferons in Tuberculosis and in Tuberculosis-Risk-Associated Comorbidities[J]. Infect Dis Rep, 2025, 17(4):81. doi:10.3390/idr17040081.
|
| [34] |
Hu X, Liu J, Shao Y, et al. Smoking Exposure and the Risk of Latent Tuberculosis Infection: Results from NHANES 2011-2012[J]. Toxics, 2024, 12(1):94. doi:10.3390/toxics12010094.
|
| [35] |
Malherbe D C, Messaoudi I. Transcriptional and Epigenetic Regulation of Monocyte and Macrophage Dysfunction by Chronic Alcohol Consumption[J]. Front Immunol, 2022, 13:911951. doi:10.3389/fimmu.2022.911951.
|
| [36] |
Lewis S A, Doratt B M, Sureshchandra S, et al. Ethanol Consumption Induces Nonspecific Inflammation and Functional Defects in Alveolar Macrophages[J]. Am J Respir Cell Mol Biol, 2022, 67(1):112-124. doi:10.1165/rcmb.2021-0346OC.
|
| [37] |
Saukkonen J J, Cohn D L, Jasmer R M, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy[J]. Am J Respir Crit Care Med, 2006, 174(8):935-952. doi:10.1164/rccm.200510-1666ST.
|
| [38] |
Herzmann C, Sotgiu G, Bellinger O, et al. Risk for latent and active tuberculosis in Germany[J]. Infection, 2017, 45(3):283-290. doi:10.1007/s15010-016-0963-2.
pmid: 27866367
|
| [39] |
Wu X, Fan X, Miyata T, et al. Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease[J]. Annu Rev Pathol, 2023, 18:411-438. doi:10.1146/annurev-pathmechdis-031521-030435.
|
| [40] |
Jiang L, Yan T, Zhang X, et al. Association between low vitamin B-12 status and latent tuberculosis infection among adults[J]. Asia Pac J Clin Nutr, 2025, 34(4):627-635. doi:10.6133/apjcn.202508_34(4).0014.
pmid: 40738730
|
| [41] |
Nasare D, Bagade S. Phytoconstituents and Immunological Responses in Tuberculosis: Insights Into Network Pharmacology[J]. Chem Biodivers, 2025, 22(11):e01727. doi:10.1002/cbdv.202501727.
|
| [42] |
Nalam S M, Chintamaneni P K, Sacena Pal R, et al. From nature’s bounty to drug discovery: Leveraging phytochemicals and molecular approaches to combat multi-drug-resistant (MDR) tuberculosis[J]. Indian J Tuberc, 2024, 71 Suppl 1:S117-S129. doi:10.1016/j.ijtb.2023.08.007.
|
| [43] |
Xu H, Zhou J, Yang Q, et al. QuantiFERON-TB supernatant-based biomarkers predicting active tuberculosis progression[J]. Int J Infect Dis, 2025, 157:107915. doi:10.1016/j.ijid.2025.107915.
|
| [44] |
Vedel J O, Furtado O, Almeida L L, et al. Refresher training in administering intradermal BCG-vaccine increased BCG-scarring rates in rural Guinea-Bissau[J]. Vaccine, 2025, 55:127039. doi:10.1016/j.vaccine.2025.127039.
|
| [45] |
Jensen T M, Jensen S K, Birk N M, et al. Determinants of Bacille Calmette-Guérin scarification in Danish children[J]. Heliyon, 2021, 7(1):e05757. doi:10.1016/j.heliyon.2020.e05757.
|
| [46] |
Shabariah R, Hatta M, Idris I, et al. Comparison TLR2 and TLR4 serum levels in children with pulmonary and extrapulmonary tuberculosis with and without a Bacillus Calmette-Guérin (BCG) scar[J]. J Clin Tuberc Other Mycobact Dis, 2021, 25:100272. doi:10.1016/j.jctube.2021.100272.
|
| [47] |
Villanueva P, Crawford N W, Croda M G, et al. Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination[J]. Heliyon, 2023, 9(4):e15241. doi:10.1016/j.heliyon.2023.e15241.
|
| [48] |
Kim H, Choi Hh, Shin S J. Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines[J]. Front Immunol, 2023, 14:1193058. doi:10.3389/fimmu.2023.1193058.
|
| [49] |
Wang W, Chen X, Chen S, et al. The burden and predictors of latent tuberculosis infection among elder adults in high epidemic rural area of tuberculosis in Zhejiang, China[J]. Front Cell Infect Microbiol, 2022, 12:990197. doi:10.3389/fcimb.2022.990197.
|
| [50] |
Cubilla-Batista I, Ruiz N, Sambrano D, et al. Overweight, Obesity, and Older Age Favor Latent Tuberculosis Infection among Household Contacts in Low Tuberculosis-Incidence Settings within Panama[J]. Am J Trop Med Hyg, 2019, 100(5):1141-1144. doi:10.4269/ajtmh.18-0927.
|
| [51] |
Cheng Q, He S, Hu Y, et al. Global, regional, and national trends in the incidence of pneumoconiosis among populations aged 20 and above from 1990 to 2021[J]. Front Public Health, 2025, 13:1608109. doi:10.3389/fpubh.2025.1608109.
|
| [52] |
Tan S, Chen S. Macrophage Autophagy and Silicosis: Current Perspective and Latest Insights[J]. Int J Mol Sci, 2021, 22(1):453. doi:10.3390/ijms22010453.
|
| [53] |
Jamshidi P, Danaei B, Arbabi M, et al. Silicosis and tuberculosis: A systematic review and meta-analysis[J]. Pulmonology, 2025, 31(1):2416791. doi:10.1016/j.pulmoe.2023.05.001.
|
| [54] |
Roy P, Bardhan M, Roy S, et al. Silico-tuberculosis amidst COVID-19 pandemic: global scenario and Indian perspective[J]. Ann Med Surg (Lond), 2023, 85(12):6083-6090. doi:10.1097/ms9.0000000000001471.
|
| [55] |
徐爽. 健康教育干预在尘肺合并肺结核患者中的应用[J]. 工业卫生与职业病, 2018, 44(5):387-388. doi:10.13692/j.cnki.gywsyzyb.2018.05.020.
|